Liver Failure – Talk Bio

FDA Threatens Action After Sarepta Refuses to Halt Elevidys Shipments

2 days ago talkbio0Tagged ELEVIDYS, gene therapy, Liver Failure, Market, Muscular Dystrophy, Duchenne, patient deaths, Regulatory Authority, United States Food and Drug Administration, Withdraw (activity)

FDA; Sarepta Therapeutics; Elevidys; gene therapy; market withdrawal; patient deaths; Duchenne muscular dystrophy; liver failure; regulatory authority

Sarepta Reports Death of DMD Patient Following Elevidys Gene Therapy Treatment

4 months ago talkbio0Tagged acute, ELEVIDYS, gene therapy, Liver Failure, Muscular Dystrophy, Duchenne

Sarepta, Elevidys, gene therapy, Duchenne muscular dystrophy, patient death, acute liver failure

Ocaliva (Obeticholic Acid) Linked to Increased Risk of Liver Failure in PBC Patients Without Cirrhosis

7 months ago talkbio0Tagged Cautionary Warning, Injury of liver, Liver Cirrhosis, Liver Failure, obeticholic acid, Ocaliva, Primary Biliary Cholangitis, United States Food and Drug Administration

Ocaliva, obeticholic acid, primary biliary cholangitis (PBC), liver failure, liver injury, cirrhosis, FDA warning.